Implant reconstruction is breast reconstruction using a silicone implant — placed at the time of mastectomy or in a staged operation — to recreate breast volume and shape, often supported by an acellular dermal matrix or synthetic mesh.
Implant reconstruction is the shorter-recovery alternative to autologous reconstruction. The operation is shorter, the hospital stay is shorter, and there is no second surgical site. The trade-off is that an implant is a device with a finite life — typically needing revision or replacement at some point — and tolerance of radiotherapy is less good than autologous tissue.
Orientation Why you might be reading about this
You may be choosing between implant and autologous reconstruction, or you have been told an implant approach is being recommended. The choice involves real trade-offs in operation length, recovery, long-term maintenance, and how the reconstruction ages over time. This page explains how implant reconstruction works and when it is the right choice.
Related terms: Autologous reconstruction · Mastectomy · Immediate reconstruction · Delayed reconstruction
The procedure How implant reconstruction works
The implant — a soft silicone-gel device shaped like a breast — is placed under the chest skin or under the chest-wall muscles to recreate breast volume. The skin envelope, preserved by skin-sparing or nipple-sparing mastectomy, sits over the top to give a natural-looking shape.
Modern implants are anatomical (teardrop-shaped) or round, smooth or textured (textured implants are now used less commonly because of safety concerns), and come in a wide range of sizes, profiles, and projections. The implant is chosen pre-operatively to match the patient’s anatomy and the desired final result.
Where the implant sits
Implants can be placed in different planes:
- Submuscular (under the pectoralis major muscle) — the traditional approach. Provides good soft-tissue cover but has the disadvantage of the implant moving with muscle contraction (the “animation deformity”).
- Pre-pectoral (under the skin only, above the muscle) — increasingly common in modern practice, using an acellular dermal matrix (ADM) to support the implant. Avoids animation deformity and gives a more natural-feeling result.
- Dual-plane — the implant is partially under and partially in front of the muscle.
The choice depends on the patient’s anatomy, the available skin envelope, and surgeon preference.
Acellular dermal matrix (ADM) and synthetic mesh
For pre-pectoral implants, an ADM — a sheet of donated and processed human or animal dermis — or a synthetic mesh is used to create an internal sling that supports the lower half of the implant. This gives a more anatomical shape and reduces the risk of implant migration. Brand names you may see in pathology reports include Strattice, AlloDerm, TiLOOP, and others.
Direct-to-implant vs two-stage
- Direct-to-implant (DTI) — the final implant is placed at the time of mastectomy. Single operation. Possible when the skin envelope is large enough and well-vascularised.
- Two-stage — a tissue expander is placed first (a temporary implant with a port that allows gradual inflation over weeks). Once the skin envelope has stretched to the desired size, a second operation replaces the expander with the final implant. Used in delayed reconstruction or when the skin envelope is small.
For modern UK practice, direct-to-implant reconstruction in a single operation is increasingly the default for selected immediate reconstructions, while two-stage approaches are used for delayed reconstruction or where the skin envelope needs to be expanded.
For the practice’s full pathway, see implant-based reconstruction service page.
The procedure What the operation involves
- Anaesthetic: general anaesthetic.
- Length of operation: 2–3 hours per side for direct-to-implant2; 1.5–2 hours for tissue expander placement; 1.5 hours for the second-stage exchange.
- Hospital stay: 1–2 nights.
- Drains: usually 1–2 drains, removed within 1–2 weeks2.
- Recovery: most patients back to desk-based work at 4 weeks2, full activity at 6–8 weeks. Significantly shorter than autologous reconstruction.
Long term Long-term considerations
Implants are devices with a finite life. Things to know about the long-term picture:
Implant longevity
- Most implants last 10–15 years before needing revision or replacement1.
- Some patients have implants that last considerably longer; others need earlier intervention because of capsular contracture, asymmetry, or implant rupture.
- Long-term, many patients can expect at least one revision operation over the lifetime of an implant reconstruction.
Capsular contracture
The body forms a thin capsule of scar tissue around any implant. In a small percentage of patients, this capsule contracts, hardening the implant and distorting the shape. Capsular contracture rates are higher after radiotherapy. Treatment options include capsulectomy (removing the capsule), capsulotomy (cutting it), and switching to a different reconstruction approach.
Implant rupture
Modern silicone implants have a low rupture rate1, particularly in the first 10 years. When rupture is suspected, MRI is the most reliable test. Treatment is usually replacement of the implant.
Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL)
A rare lymphoma associated predominantly with macrotextured implants (UK MHRA pooled estimate roughly 1 in 12,000–15,000 implants sold). Allergan Biocell macrotextured devices were withdrawn in the UK. There are no confirmed cases in implants that were only ever smooth. Presenting as late seroma or swelling; treatable when caught early. MHRA requires BIA-ALCL to be discussed at consent.
Breast implant illness (BII)
Some patients report clusters of systemic symptoms they attribute to implants (fatigue, joint pain, brain fog). BII is not a proven diagnosis and MHRA monitoring continues, but symptoms should be reported and discussed at consultation.
Implant details are submitted to the NHS Breast and Cosmetic Implant Registry (BCIR) for traceability.
Long-term monitoring
Patients with implants are advised to be aware of changes (size, shape, firmness, new fluid collection) and to seek prompt review if anything changes. Implant details are recorded on the NHS Breast and Cosmetic Implant Registry (BCIR) so patients can be traced if a product recall is issued. Routine imaging surveillance for implant integrity is not generally needed in asymptomatic patients but can be considered.
Comparison Comparing to autologous reconstruction
| Implant reconstruction | Autologous reconstruction | |
|---|---|---|
| Operation length | 2–3 hours | 6–10 hours |
| Hospital stay | 1–2 nights | 4–5 nights |
| Full recovery | 6–8 weeks | 3–6 months |
| Donor site | None | Yes — abdomen, thigh, back, or lower back |
| Long-term maintenance | Implants typically need revision/replacement over time | Usually none; revision uncommon |
| Tolerance of radiotherapy | Less good — capsular contracture risk | Better |
| Cosmetic feel | Firmer; shape is fixed | Soft; ages with the body |
The right choice depends on the patient’s priorities. Some patients strongly prefer the shorter operation and faster recovery of implant reconstruction; others prefer the natural-feel and longevity of autologous tissue.
At consultation What to discuss at consultation
If implant reconstruction is being considered:
- The implant type and plane — pre-pectoral or submuscular, with or without ADM/mesh.
- Direct-to-implant vs staged — single operation or two-stage.
- Long-term implications — likely revision operations over the lifetime of the implant.
- Radiotherapy considerations — if radiotherapy is planned, the choice may shift towards autologous reconstruction or delayed reconstruction.
- What the realistic cosmetic outcome is — usually shown at consultation with photographs.
- What to monitor for over the long term — capsular contracture, rupture, BIA-ALCL signs.
Resources Further reading
- NHS — Breast cancer: Treatment — patient overview.
- Breast Cancer Now — Breast reconstruction using a breast implant — patient-focused guide.
- MHRA — Breast implants — UK regulator information including BIA-ALCL.
- NHS Digital — Breast and Cosmetic Implant Registry (BCIR) — UK implant traceability registry.
- NHS Digital — Breast and Cosmetic Implant Registry (BCIR) — UK implant traceability registry.
- Breastory: Reconstruction overview · Implant-based reconstruction service page · Glossary: autologous reconstruction